T. Shantha Raju, Ph.D., is a proven research and development executive with expertise in building and advancing highly effective discovery programs. With more than 20 years of experience at leading companies including Genentech, Johnson & Johnson, and Medimmune, Dr. Raju has a successful track record of drug development in multiple therapeutic areas.
Specifically, Dr. Raju has worked on all stages of development - from discovery to licensing and beyond. He has experience with both biological and small molecule drug development and has developed an expertise in structure-activity relationship (SAR) studies. He also has a strong regulatory background, having worked extensively with Investigational New Drug (IND) filings and Biologics Licensing Applications (BLA). He has worked extensively on addressing the Chemistry, Manufacturing, and Controls (CMC) portion of IND applications and has developed competencies in outsourcing and integrating external experts and resources with focused internal R&D teams, including management of contract research and manufacturing projects.
Dr. Raju obtained his Ph.D. in bio-organic chemistry and has helped in the development of numerous patented therapies. He also has 48 peer-reviewed scholarly publications and more than 150 scholarly presentations.